Effect of thromboxane A2 synthesis inhibitor OKY046 on canine pancreas and kidney preservation.
Kin
S
S
Department of Surgery, University of Minnesota, Minneapolis.
Stephanian
E
E
Gores
P
P
Moss
A
A
Shinagawa
Y
Y
Barrou
B
B
Gruessner
R
R
Tamura
K
K
Sutherland
D E
DE
D000241:Adenosine; D000493:Allopurinol; D000818:Animals; D004285:Dogs; D005260:Female; D005978:Glutathione; D007328:Insulin; D016030:Kidney Transplantation / Q000473:pathology / Q000502:physiology*; D008099:Liver / Q000187:drug effects; D008297:Male; D008689:Methacrylates / Q000494:pharmacology*; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D010179:Pancreas / Q000187:drug effects; D016035:Pancreas Transplantation / Q000473:pathology / Q000502:physiology*; D011887:Raffinose; D012996:Solutions; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D013997:Time Factors
D007328:Insulin; D008689:Methacrylates; D019188:Organ Preservation Solutions; D012996:Solutions; C055206:University of Wisconsin-lactobionate solution; D013928:Thromboxane A2; D000493:Allopurinol; D013930:Thromboxane-A Synthase; D005978:Glutathione; D000241:Adenosine; C034364:ozagrel; D011887:Raffinose